These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16728943)

  • 1. Update on the management of inflammatory breast cancer.
    Buzdar AU
    Clin Adv Hematol Oncol; 2006 May; 4(5):344-5. PubMed ID: 16728943
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory breast cancer: defining a new entity.
    Cristofanilli M
    Semin Oncol; 2008 Feb; 35(1):6. PubMed ID: 18308139
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of locoregional therapy in inflammatory breast cancer.
    Woodward WA; Buchholz TA
    Semin Oncol; 2008 Feb; 35(1):78-86. PubMed ID: 18308149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings of the First International Inflammatory Breast Cancer Conference.
    Cristofanilli M; Buchholz TA
    Cancer; 2010 Jun; 116(11 Suppl):2729. PubMed ID: 20503400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inflammatory breast cancer].
    Valsassina MV
    Acta Med Port; 2002; 15(6):461-4. PubMed ID: 12680294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory breast cancer: patient advocate view.
    Mason G; Johnson O
    Semin Oncol; 2008 Feb; 35(1):87-91. PubMed ID: 18308150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of a patient with inflammatory breast cancer.
    Mason G
    Oncology (Williston Park); 2008 Jul; 22(8 Suppl Nurse Ed):29-32. PubMed ID: 19856568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remembering inflammatory breast cancer. Are you up to date on management and treatment?
    Penn CL
    J Ark Med Soc; 2007 Oct; 104(4):80-2. PubMed ID: 17953196
    [No Abstract]   [Full Text] [Related]  

  • 9. Management and prognosis of breast cancer.
    Bland KI
    Med Sect Proc; 1991; ():33-47. PubMed ID: 1821945
    [No Abstract]   [Full Text] [Related]  

  • 10. p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer.
    Yamashita H; Toyama T; Nishio M; Ando Y; Hamaguchi M; Zhang Z; Kobayashi S; Fujii Y; Iwase H
    Breast Cancer Res; 2006; 8(4):R48. PubMed ID: 16869955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and histomorphometric methods in the assessment of prognosis in breast cancer].
    Aaltomaa S; Lipponen P; Eskelinen M
    Duodecim; 1992; 108(16):1383-9. PubMed ID: 1366156
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2.
    Svane IM; Pedersen AE; Nikolajsen K; Zocca MB
    Vaccine; 2008 Aug; 26(36):4716-24. PubMed ID: 18616968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of cancer-related fatigue.
    Bower JE
    Clin Adv Hematol Oncol; 2006 Nov; 4(11):828-9. PubMed ID: 17143252
    [No Abstract]   [Full Text] [Related]  

  • 14. Inflammatory breast cancer and high-dose chemotherapy: back to the past.
    Gonzalez-Angulo AM; Morandi P; Cristofanilli M
    J Clin Oncol; 2005 Jun; 23(16):3859-60; author reply 3860-2. PubMed ID: 15923586
    [No Abstract]   [Full Text] [Related]  

  • 15. The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
    Ko SS; Na YS; Yoon CS; Park JY; Kim HS; Hur MH; Lee HK; Chun YK; Kang SS; Park BW; Lee JH
    Int J Surg Pathol; 2007 Apr; 15(2):98-109. PubMed ID: 17478762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c.
    Kyndi M; Sørensen FB; Knudsen H; Alsner J; Overgaard M; Nielsen HM; Overgaard J
    Acta Oncol; 2008; 47(4):608-17. PubMed ID: 18465329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the management of inflammatory breast cancer.
    Cristofanilli M; Buzdar AU; Hortobágyi GN
    Oncologist; 2003; 8(2):141-8. PubMed ID: 12697939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of inflammatory breast cancer and noninflammatory breast cancer in Western Turkey.
    Saydam BK; Goksel G; Korkmaz E; Zekioglu O; Kapkac M; Sanli UA; Uslu R; Sezgin C
    Med Princ Pract; 2008; 17(6):475-80. PubMed ID: 18836277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is triple negative a prognostic factor in breast cancer?
    Nishimura R; Arima N
    Breast Cancer; 2008; 15(4):303-8. PubMed ID: 18369692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.